Kynam Capital Management, LP 13D and 13G filings for Viridian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 12:17 pm Purchase | 2026-06-30 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Kynam Capital Management, LP | 6,453,877 5.700% | 4,983,336 (+338.88%) | Filing |
| 2026-02-17 12:52 pm Sale | 2025-12-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Kynam Capital Management, LP | 1,470,541 1.540% | -3,229,459 (-68.71%) | Filing |
| 2025-05-15 11:44 am Purchase | 2025-03-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Kynam Capital Management, LP | 4,700,000 5.760% | 4,700,000 (New Position) | Filing |